These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12151844)

  • 21. [Atypical Parkinsonian syndromes, a challenging group of diseases].
    Liimatainen S; Haapasalo H; Kähärä V; Paetau A; Honkaniemi J
    Duodecim; 2005; 121(16):1757-66. PubMed ID: 16268222
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of molecular imaging in the differential diagnosis of parkinsonism.
    Booij J; Teune LK; Verberne HJ
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):17-26. PubMed ID: 22460157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Olfactory dysfunction in parkinsonian syndromes. Its role in early and differential diagnosis].
    Herting B
    Fortschr Neurol Psychiatr; 2010 Aug; 78(8):483-9; quiz 490-3. PubMed ID: 20694943
    [No Abstract]   [Full Text] [Related]  

  • 24. Ocular motor abnormalities in Parkinsonian syndromes.
    Pinkhardt EH; Kassubek J
    Parkinsonism Relat Disord; 2011 May; 17(4):223-30. PubMed ID: 20801069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice.
    Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J
    Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 128-channel somatosensory evoked potentials in the differential diagnosis of parkinsonian disorders.
    van de Wassenberg WJ; van der Hoeven JH; Leenders KL; Maurits NM
    Parkinsonism Relat Disord; 2009 Sep; 15(8):564-71. PubMed ID: 19303347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Parkinsonian disorders: from clinical manifestations to diagnostic classification].
    Bourdain F; Tir M; Trocello JM
    Rev Med Interne; 2013 Sep; 34(9):528-37. PubMed ID: 23142125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders.
    Litvan I; Bhatia KP; Burn DJ; Goetz CG; Lang AE; McKeith I; Quinn N; Sethi KD; Shults C; Wenning GK;
    Mov Disord; 2003 May; 18(5):467-86. PubMed ID: 12722160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
    Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
    Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic criteria for Parkinson's disease.
    Albanese A
    Neurol Sci; 2003 May; 24 Suppl 1():S23-6. PubMed ID: 12774207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic criteria and differential diagnosis of Parkinson disease].
    Takáts A
    Ideggyogy Sz; 2003 May; 56(5-6):144-54. PubMed ID: 12861955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.
    Vlaar AM; de Nijs T; van Kroonenburgh MJ; Mess WH; Winogrodzka A; Tromp SC; Weber WE
    BMC Neurol; 2008 Nov; 8():42. PubMed ID: 18992168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.
    Bruns MB; Josephs KA
    Int Rev Psychiatry; 2013 Apr; 25(2):197-209. PubMed ID: 23611349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New advances in tau imaging in parkinsonism.
    Valli M; Strafella AP
    Int Rev Psychiatry; 2017 Dec; 29(6):628-635. PubMed ID: 29206491
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Meyer PT; Frings L; Rücker G; Hellwig S
    J Nucl Med; 2017 Dec; 58(12):1888-1898. PubMed ID: 28912150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study of the pre and post-synaptic dopaminergic system by DaTSCAN/IBZM SPECT in the differential diagnosis of parkinsonism in 75 patients].
    Vaamonde J; Ibáñez R; García AM; Poblete V
    Neurologia; 2004; 19(6):292-300. PubMed ID: 15199417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pearls: parkinsonism.
    Ahlskog JE
    Semin Neurol; 2010 Feb; 30(1):10-4. PubMed ID: 20127575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.